METTL3 and neoplasm: Immunohistochemistry (IHC) staining of bladder cancer patient tumor microarray revealed that both METTL3 and CDCP1 are moderately or highly expressed in most of the bladder cancer samples, whereas their expression are weak or not detectable in the majority of the paratumor controls (Fig. 6a).